Managing leptospirosis in dogs

Veterinary Medicine

Volumn 98, Issue 7, 2003, Pages 586-594

  Carr, Anthony ^a   Nielssen, Astrid ^a   Heseltine, Johanna ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; DOXYCYCLINE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFONAMIDE;

CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; ECHOGRAPHY; INFECTION PREVENTION; LEPTOSPIROSIS; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PROGNOSIS; TREATMENT OUTCOME; ZOONOSIS;

CANIS FAMILIARIS;

EID: 0042745522     PISSN: 87507943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Lomar, A.V. et al.: Leptospirosis in Latin America. Infect. Dis. Clin. North Am. 14 (1):23-39; 2000.
2. Ward, M.P. et al.: Prevalence of and risk factors for leptospirosis among dogs in the United States and Canada: 677 cases (1970-1998). JAVMA 220 (1): 53-58; 2002.
3. Levitan, D.M.: Did you consider leptospirosis? Vet. Forum 15:42-50; 1998.
4. Plank, R.; Dean, D.: Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microbes Infect. 2 (10):1265-1276; 2000.
5. Greene, C.E. et al.: Leptospirosis. Infectious Diseases of the Dog and Cat, 2nd Ed. (C.E. Greene, ed.). W.B. Saunders, Philadelphia, Pa., 1998; pp 273-281.
6. Birnbaum, N. et al.: Naturally acquired leptospirosis in 36 dogs: Serological and clinicopathological features. J. Small Anim. Pract 39 (5):231-236; 1998.
7. Rentko, V.T. et al.: Canine leptospirosis: A retrospective study of 17 cases. J. Vet. Intern Med. 6 (4):235-244; 1992.
8. Harkin, K.R.; Gartrell, C.L.: Canine leptospirosis in New Jersey and Michigan: 17 cases (1990-1995).JAAHA 32 (6):495-501; 1996.
9. Adin, C.A.; Cowgill, L.D.: Treatment and outcome of dogs with leptospirosis: 36 cases (1990-1998). JAVMA 216 (3):371-375; 2000.
10. Stokes, J.E. et al.: Prevalence of serum antibodies to six Leptospira interrogans serovars in asymptomatic dogs from the lower peninsula of Michigan (abst.). Proc. ACVIM, ACVIM, Denver, Colo., 2001; p 880.
11. Yang, C.W. et al.: Leptospira outer membrane protein activates NF-kappaB and downstream genes expressed in medullary thick ascending limb cells. J. Am. Soc. Nephrol. 11 (11):2017-2026; 2000.
12. Younes-Ibrahim, M. et al.: Inhibition of Na,K-ATPase by an endotoxin extracted from Leptospira interrogans: A possible mechanism for the physiopathology of leptospirosis. C. R. Acad. Sci III 318 (5):619-625; 1995.
13. Wollanke, B. et al.: Serum and vitreous humor antibody titers in and isolation of Leptospira interrogans from horses with recurrent uveitis. JAVMA 219 (6):795-800; 2001.
14. Adamus, C. et al.: Chronic hepatitis associated with leptospiral infection in vaccinated beagles. J. Comp. Pathol. 117 (4):311-328; 1997.
15. Baumann, D.; Flueckiger, M.: Radiographic findings in the thorax of dogs with leptospiral infection. Vet. Radiol. Ultrasound 42 (4):305-307; 2001.
16. Forrest, L.J. et al.: Sonographic renal findings in 20 dogs with leptospirosis. Vet Radiol. Ultrasound 39 (4):337-340; 1998.
17. Ribotta, M.J. et al.: Development of an indirect enzyme-linked immunosorbent assay for the detection of leptospiral antibodies in dogs. Can. J. Vet. Res. 64 (1):32-37; 2000.
18. Coyne, M.J. et al.: Duration of immunity in dogs after vaccination or naturally acquired infection. Vet. Rec. 149 (17):509-515; 2001.